| Risk factors for coronavirus disease 2019 (COVID-19) death in a population cohort study from the Western Cape Province, South Africa Clinical Infectious Diseases 73 (7), e2005-e2015, 2021 | 580 | 2021 |
| T cell responses to SARS-CoV-2 spike cross-recognize Omicron R Keeton, MB Tincho, A Ngomti, R Baguma, N Benede, A Suzuki, K Khan, ... Nature 603 (7901), 488-492, 2022 | 549 | 2022 |
| Post-tuberculosis lung health: perspectives from the First International Symposium BW Allwood, MM Van Der Zalm, AFS Amaral, A Byrne, S Datta, U Egere, ... The International Journal of Tuberculosis and Lung Disease 24 (8), 820-828, 2020 | 198 | 2020 |
| Prednisone for the prevention of paradoxical tuberculosis-associated IRIS G Meintjes, C Stek, L Blumenthal, F Thienemann, C Schutz, J Buyze, ... New England Journal of Medicine 379 (20), 1915-1925, 2018 | 186 | 2018 |
| Relationship of SARS-CoV-2–specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection C Riou, E Du Bruyn, C Stek, R Daroowala, RT Goliath, F Abrahams, ... The Journal of clinical investigation 131 (12), 2021 | 162 | 2021 |
| Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunity C Riou, R Keeton, T Moyo-Gwete, T Hermanus, P Kgagudi, R Baguma, ... Science translational medicine 14 (631), eabj6824, 2021 | 97 | 2021 |
| The immune mechanisms of lung parenchymal damage in tuberculosis and the role of host-directed therapy C Stek, B Allwood, NF Walker, RJ Wilkinson, L Lynen, G Meintjes Frontiers in microbiology 9, 2603, 2018 | 96 | 2018 |
| The tuberculosis-associated immune reconstitution inflammatory syndrome: recent advances in clinical and pathogenesis research NF Walker, C Stek, S Wasserman, RJ Wilkinson, G Meintjes Current Opinion in HIV and AIDS 13 (6), 512-521, 2018 | 85 | 2018 |
| SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron R Keeton, MB Tincho, A Ngomti, R Baguma, N Benede, A Suzuki, K Khan, ... MedRxiv, 2021.12. 26.21268380, 2021 | 61 | 2021 |
| The long shadow post-tuberculosis B Allwood, M van der Zalm, G Makanda, K Mortimer, AA FS, E Uzochukwu, ... The Lancet Infectious Diseases 19 (11), 1170-1171, 2019 | 55 | 2019 |
| Plasma pharmacokinetics of high-dose oral versus intravenous rifampicin in patients with tuberculous meningitis: a randomized controlled trial S Wasserman, A Davis, C Stek, M Chirehwa, S Botha, R Daroowala, ... Antimicrobial agents and chemotherapy 65 (8), 10.1128/aac. 00140-21, 2021 | 31 | 2021 |
| Neuralgic amyotrophy associated with Bartonella henselae infection CJ Stek, JJJ Van Eijk, BC Jacobs, RH Enting, HG Sprenger, N Van Alfen, ... Journal of Neurology, Neurosurgery & Psychiatry 82 (6), 707-708, 2011 | 31 | 2011 |
| Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa E Du Bruyn, C Stek, R Daroowala, Q Said-Hartley, M Hsiao, G Schafer, ... Nature communications 14 (1), 188, 2023 | 24 | 2023 |
| Two donor-related infections in a heart transplant recipient: one common, the other a tropical surprise J Brügemann, GA Kampinga, A Riezebos-Brilman, CJ Stek, JP Edel, ... The Journal of heart and lung transplantation 29 (12), 1433-1437, 2010 | 24 | 2010 |
| The effect of HIV-associated tuberculosis, tuberculosis-IRIS and prednisone on lung function C Stek, B Allwood, E Du Bruyn, J Buyze, C Schutz, F Thienemann, ... European Respiratory Journal 55 (3), 2020 | 23 | 2020 |
| A phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for human immunodeficiency virus–associated … AG Davis, S Wasserman, C Stek, M Maxebengula, C Jason Liang, ... Clinical Infectious Diseases 76 (8), 1412-1422, 2023 | 21 | 2023 |
| Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2-specific T-cells C Riou, G Schäfer, E Du Bruyn, RT Goliath, C Stek, H Mou, D Hung, ... European Respiratory Journal 59 (1), 2022 | 20 | 2022 |
| Preventing paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in high-risk patients: protocol of a randomized placebo-controlled trial of … C Stek, C Schutz, L Blumenthal, F Thienemann, J Buyze, C Nöstlinger, ... JMIR Research Protocols 5 (3), e6046, 2016 | 15 | 2016 |
| Pegylated interferon-α monotherapy leads to low response rates in HIV-infected patients with acute hepatitis C JE Arends, S van Assen, CJ Stek, AMJ Wensing, JH Fransen, ... Antiviral therapy 16 (7), 979-988, 2011 | 13 | 2011 |
| Cognitive impairment in tuberculous meningitis AG Davis, AJ Dreyer, C Albertyn, M Maxebengula, C Stek, S Wasserman, ... Clinical Infectious Diseases 76 (5), 842-849, 2023 | 12 | 2023 |
